Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETHAN: Endocrine Therapies for Male Breast Cancer
NCT05501704Phase 2Recruiting
- Sponsor
- Jose Pablo Leone
- Start
- Oct 2023
- Primary completion
- Apr 2027
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole, degarelix, abemaciclib in breast cancer, sponsored by Jose Pablo Leone. Started Oct 2023; status: recruiting.
02
Drugs
anastrozoledegarelixabemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05501704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05501704.